These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31323736)

  • 1. Dietary Cholesterol Is Highly Associated with Severity of Hyperlipidemia and Atherosclerotic Lesions in Heterozygous LDLR-Deficient Hamsters.
    Wang J; He K; Yang C; Lin X; Zhang X; Wang Y; Liu G; Xian X
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31323736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis.
    Guo X; Gao M; Wang Y; Lin X; Yang L; Cong N; An X; Wang F; Qu K; Yu L; Wang Y; Wang J; Zhu H; Xian X; Liu G
    EBioMedicine; 2018 Jan; 27():214-224. PubMed ID: 29289533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
    Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis.
    Wu Y; Xu MJ; Cao Z; Yang C; Wang J; Wang B; Liu J; Wang Y; Xian X; Zhang F; Liu G; Chen X
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans.
    Thompson GR
    Atherosclerosis; 2018 Sep; 276():148-154. PubMed ID: 30064057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7.
    Lu R; Yuan T; Wang Y; Zhang T; Yuan Y; Wu D; Zhou M; He Z; Lu Y; Chen Y; Fan J; Liang J; Cheng Y
    EBioMedicine; 2018 Oct; 36():29-38. PubMed ID: 30243490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interspecies study of lipid profiles and atherosclerosis in familial hypercholesterolemia animal models with low-density lipoprotein receptor deficiency.
    He K; Wang J; Shi H; Yu Q; Zhang X; Guo M; Sun H; Lin X; Wu Y; Wang L; Wang Y; Xian X; Liu G
    Am J Transl Res; 2019; 11(5):3116-3127. PubMed ID: 31217881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet.
    Ma Y; Wang W; Zhang J; Lu Y; Wu W; Yan H; Wang Y
    PLoS One; 2012; 7(4):e35835. PubMed ID: 22558236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic NPC1L1 promotes hyperlipidemia in LDL receptor deficient mice.
    Wang Y; Tang W; Yang P; Shin H; Li Q
    Biochem Biophys Res Commun; 2018 May; 499(3):626-633. PubMed ID: 29601818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue deficiency results in severe hyperlipidemia and atherosclerosis in the low-density lipoprotein receptor knockout mice.
    Wang M; Gao M; Liao J; Qi Y; Du X; Wang Y; Li L; Liu G; Yang H
    Biochim Biophys Acta; 2016 May; 1861(5):410-8. PubMed ID: 26921684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in Coronary Atherosclerosis Severity Related to a Distinct LDL (Low-Density Lipoprotein) Profile: Findings From a Familial Hypercholesterolemia Pig Model.
    Hoogendoorn A; den Hoedt S; Hartman EMJ; Krabbendam-Peters I; Te Lintel Hekkert M; van der Zee L; van Gaalen K; Witberg KT; Dorst K; Ligthart JMR; Drouet L; Van der Heiden K; van Lennep JR; van der Steen AFW; Duncker DJ; Mulder MT; Wentzel JJ
    Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2338-2352. PubMed ID: 31554418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idol Depletion Protects against Spontaneous Atherosclerosis in a Hamster Model of Familial Hypercholesterolemia.
    Liang C; Wang X; Peng K; Lai P; Liu Z; Ma J; Chen X; Liu G; Zheng M; Wang Y; Yang H; Liu G; Xian X; Gao M
    Oxid Med Cell Longev; 2022; 2022():1889632. PubMed ID: 35656026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia.
    Jacobs F; Van Craeyveld E; Feng Y; Snoeys J; De Geest B
    Atherosclerosis; 2008 Dec; 201(2):289-97. PubMed ID: 18378244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas-mediated genetic correction, and productive hepatitis C virus infection.
    Caron J; Pène V; Tolosa L; Villaret M; Luce E; Fourrier A; Heslan JM; Saheb S; Bruckert E; Gómez-Lechón MJ; Nguyen TH; Rosenberg AR; Weber A; Dubart-Kupperschmitt A
    Stem Cell Res Ther; 2019 Jul; 10(1):221. PubMed ID: 31358055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercholesterolemia and atherosclerosis in low density lipoprotein receptor mutant rats.
    Asahina M; Mashimo T; Takeyama M; Tozawa R; Hashimoto T; Takizawa A; Ueda M; Aoto T; Kuramoto T; Serikawa T
    Biochem Biophys Res Commun; 2012 Feb; 418(3):553-8. PubMed ID: 22293196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
    Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
    Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia.
    Xu Y; Guo J; Zhang L; Miao G; Lai P; Zhang W; Liu L; Hou X; Wang Y; Huang W; Liu G; Gao M; Xian X
    Front Cardiovasc Med; 2022; 9():840358. PubMed ID: 35187136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice.
    Kirk EA; Sutherland P; Wang SA; Chait A; LeBoeuf RC
    J Nutr; 1998 Jun; 128(6):954-9. PubMed ID: 9614153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depleting LCAT Aggravates Atherosclerosis in LDLR-deficient Hamster with Reduced LDL-Cholesterol Level.
    Lin X; Zhang W; Yang C; Ma P; He K; Chen G; Tao Y; Yan H; Yang Z; Zhang L; Fan J; Cui Q; Huang W; Liu G; Xian X; Wang Y
    J Adv Res; 2023 Nov; ():. PubMed ID: 37923248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.